Table 4

Secondary outcomes, symptoms following the treatment, by provider

Secondary outcomesMidwifePhysicianTotal
Bleeding since treatment
N 408401806
 Less than normal menstrual bleeding274 (67%)268 (67%)542 (67%)
 Same as normal menstrual bleeding78 (19%)70 (18%)148 (19%)
 Heavier than normal menstrual bleeding56 (14%)60 (15%)116 (14%)
Days bleeding
 N396389785
 Mean4.2 (2.0)4.08 (1.7)4.1 (2.0)
 Range1–141–101–14
Pain following treatment
 N407399806
 None86 (21%)84 (20%)170 (21%)
 Mild200 (49%)194 (49%)394 (49%)
 Moderate81 (20%)76 (19%)157 (20%)
 Severe40 (10%)45 (11%)85 (10%)
Unscheduled visit
 N403397800
 Yes20 (5%)26 (6%)46 (6%)
 Vaginal bleeding or abdominal pain, or both11 (3%)18 (4%)29 (4%)
 Chill/fever or dizziness, or both6 (1%)6 (1%)12 (1%)
Acceptance of the method
 How did you perceive the treatment
 N407398801
 As expected121 (30%)130 (32%)251 (31%)
 Worse than expected29 (7%)27 (7%)56 (7%)
 Easier than expected257 (63%)241 (61%)498 (62%)
 Felt safe
 N400399799
 Yes383 (96%)378 (95%)779 (97%)
 No17 (4%)21 (4%)38 (3%)
 Will recommend the treatment to a friend
 N400399799
 Yes383 (96%)378 (95%)761 (95%)
 No17 (4%)21 (5%)38 (5%)
  • Data are n (%) unless otherwise stated.

  • Internal drop-out range between 0–11 (0%–2.6%), among the midwife and physician group, respectively.